Ads
related to: current treatments for alzheimer's- TruStem Cell Reviews
Read reviews from our patients
and see why TruStem is top rated.
- Stem Cell FAQs
Discover questions about stem cell
therapy and the TruStem difference.
- How to Become a Patient
Learn how easy it is to become a
TruStem Cell Therapy patient
- Our Treatment Center
Learn about each doctor, clinician
and our state-of-the-art facility.
- TruStem Cell Difference
Learn why we are the most advanced
adult stem cell therapy in the US
- About Us
Our mission and values which drive
us toward changing patient lives
- TruStem Cell Reviews
Search results
Results From The WOW.Com Content Network
The new study, a phase 2 clinical trial, included 32 volunteers with Alzheimer’s disease, aged 56 to 88 at the start of the study, who were followed for 52 weeks. Sixteen of the participants who ...
Aducanumab, sold under the brand name Aduhelm, is an anti-amyloid drug designed to treat Alzheimer's disease. It is a monoclonal antibody that targets aggregated forms (plaque) of amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup. [10] It was developed by Biogen and Eisai. [11] Aducanumab is given via intravenous infusion. [5] Aducanumab was ...
Editor's note: A previous version of this article incorrectly stated that Eli Lilly's experimental drug solanezumab is a BACE inhibitor, and incorrectly noted the dates that Prana will release its ...
New research shows that glial cells play an important role in producing amyloid beta, a protein linked to Alzheimer’s disease. The study, undertaken by scientists at the Max Planck Institute ...
Alzheimer's disease (AD) is a neurodegenerative disease that usually starts slowly and progressively worsens. [2] It is the cause of 60–70% of cases of dementia. [2] [15] The most common early symptom is difficulty in remembering recent events. [1]
Solanezumab was safely used in combination with approved Alzheimer's disease treatment, such as acetylcholinesterase inhibitors or memantine, in the clinical trials. [1] [7] [8] Aside from Alzheimer's disease, there are other amyloid beta related diseases, in which solanezumab could be used, e.g., Down syndrome or cerebral amyloid angiopathy. [9]
Ads
related to: current treatments for alzheimer's